The development of novel carriers for gene therapy of tumours

Projektinformationen

ID Finanzhilfevereinbarung: QLGA-CT-1999-51493

Startdatum

Enddatum

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 0,00

EU-Beitrag Keine Daten

Koordiniert durch

Rijksuniversiteit Groningen
Netherlands

Ziel

The purpose of this project is to develop novel synthetic amphiphile formulations, which express a higher delivery efficiency and cell/tissue specificity. The next step will be applying the systems as developed in a comparative study that relies upon gene expression in vitro versus in vivo.

Wissenschaftliches Gebiet

• medical and health sciences › medical biotechnology › genetic engineering › gene therapy

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

Data not available

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

Rijksuniversiteit Groningen

• EU-Beitrag: Keine Daten
• Adresse: A. Deusinglaan 1 ; 9713 AV Groningen ; Niederlande
• Gesamtkosten: Keine Daten

Beteiligte (1)

Not available

Polen

• EU-Beitrag: Keine Daten
• Gesamtkosten: Keine Daten